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Background: Obesity and Type 2 Diabetes are both global epidemics that continue to 
skyrocket. High basal plasma lactate levels, reduced oxidative capacity, and insulin resistance 
are co-morbidities with these metabolic disorders.  However, it is unknown if those co-morbid 
traits are also displayed in the non-obese who may be predisposed to obesity. A higher plasma 
lactate concentration is the product of the shift to anaerobic glycolysis due to the reduction of 
oxidative capacity. With aerobic respiration being limited, we believed it would reduce the 
resting energy expenditure (REE), and potentially propel an individual toward obesity and 
related metabolic disease(s). Purpose: The purpose of the study was to investigate if plasma 
lactate can be used to predict resting energy expenditure in non-obese humans. Methods: Non-
obese subjects (n=40) with body mass index (BMI) between 18.5-26.0 kg/m2 were screened for 
plasma lactate concentration. Subjects with the highest (n=10) and lowest (n=11) plasma lactate 
were selected and grouped into a High Lactate (High) and a Low Lactate (Low) Group. Both 
groups had their body composition, REE, resting respiratory exchange ratio (RER), and aerobic 
capacity (VO2 peak) assessed on the first testing day. Blood measurements, and oxidative 
capacity were assessed using near infrared spectroscopy (NIRS), and submaximal exercise RER 
(low intensity at 50% VO2 peak) were assessed on the second testing day. Results: Lactate and 
REE were negatively correlated (R=-0.6093) in the High Lactate Group. This correlation was 
stronger when REE was adjusted for fat free mass (FFM) (R=-0.6823, P<0.05). Aerobic capacity 
adjusted for FFM was significantly lower in the High Lactate Group (P<0.05). Lactate and 
aerobic capacity adjusted for FFM also revealed a strong relationship (R=-0.7232, P<0.001). 
Lactate and oxidative capacity demonstrated a negative relationship (R=-0.364) in the High 
Lactate Group. Lactate and substrate change (ΔRER) from resting to submaximal exercise were 
strongly correlated (R=0.6393, P<0.05).  Laboratory blood analysis showed no difference in 
plasma lactate, insulin or glucose. Conclusion: Lactate is associated with resting energy 
expenditure in non-obese Caucasian females. The inability for higher lactate individuals to match 
more fat substrates utilized as the lower lactate subjects may be an indication of a lesser 
mitochondrial and capillary density. The implication of early signs of elevated lactate 
concentrations may be an indicator of a compromised energy transduction capacity, which may 
be a contributor to obesity. Further research is needed to look at the plasma lactate concentration, 
and oxidative capacity affecting energy expenditure.
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Chapter I: Introduction 
 Obesity is one of the largest health epidemics in North America 1. The excessive weight 
gain among the U.S. population is one of the main contributors to metabolic diseases and 
negative health related risk factors 1. These diseases include Type 2 Diabetes, cardiovascular 
disease (CVD), hypertension, and dyslipidemia 2. Body mass index (BMI) is a widely used tool 
to categorize bodyweight as a risk factor for obesity. BMI is a fast and simple way to predict 
global health risks and it has also been shown to be highly associated with all-cause mortality. 
As a person deviates further above the normal BMI range (18.5-24.9 kg/m2), mortality and 
morbidity increases 3,4. Obesity is defined with a BMI above 30.0 kg/m2, and obesity related risk 
factors such as cardiovascular disease, hypertension, Type 2 Diabetes, are magnified even further 
when accompanied with a sedentary lifestyle 5. Moreover, the cost associated with obesity 
continues to rise. It is estimated that Americans spend between 147 to 210 billion dollars 
annually on obesity related health issues 6. The annual cost for treating an obese woman is 
around $4,879 and $2,646 for an obese man. According to the Center for Disease Control 
Prevention, close to 40% of the U.S population is obese 2. If this epidemic continues, the cost is 
projected to reach up to $580 billion by year of 2030 7.  
Metabolic diseases become more prevalent the more obese an individual becomes 8. To 
understand more on the topic of obesity and obesity related diseases, we were interested in 
looking at the biomarker plasma lactate in the non-obese to see if it can be served as a predictor 
of resting energy expenditure. In the basal/resting state, plasma lactate concentrations of 0.5-1.0 
mmol/L has been suggested to be indicative of a lower risk for developing metabolic diseases, 
while levels above 2.5 mmol/L have a significantly higher association 4,9–11. In the normal 
healthy state, low plasma lactate levels are expected. Plasma lactate serves as a good indicator of 
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an individual’s substrate oxidative capacity. The problem arises when there is a larger 
concentration of lactate within the blood. This is noted in the presence of a low mitochondrial 
oxidative capacity, which has been associated with dysfunction of the pathway involved the 
Tricarboxylic Acid Cycle (TCA) observed in the obese state 12–14. Evidence suggests that the 
pathway for the TCA Cycle has been mechanistically attenuated, which results in a shift of 
substrate utilization away from lipids/fatty acids (and carbohydrate) toward anaerobic 
metabolism of carbohydrate 15,16. It is known that high lactate concentration is associated with 
both obesity and Type 2 Diabetes 11,17. However, the characteristics of individuals with elevated 
lactate above the normal level has not been thoroughly investigated in the non-obese state with 
no known diagnosis of metabolic or cardiovascular diseases. We believed that high lactate 
concentration is an indication for lower oxidative capacity, which would reflect a lower resting 
energy expenditure (REE), and resting higher RER.   
The purpose of the study was to focus in the direction towards plasma lactate prediction 
of resting energy expenditure in non-obese humans. The hypothesis entertained currently is that a 
reduced energy substrate (carbohydrates or fats) oxidative capacity leads to heightened anaerobic 
metabolism of carbohydrates due to an inability to shift between carbohydrate and fat substrates 
for oxidation 18,19. As such, we hypothesized that resting lactate levels in the blood would be 
predictive of an individual’s REE. 
In relation to REE, it is imperative to address the characteristics of skeletal muscle 
bioenergetics in terms of fuel metabolism. Possessing high levels of fat mass and low levels of 
physical activity is associated with a low muscle mass, which can lead to low whole body 
oxidative capacity. Skeletal muscle obtains energy through competing substrates between 




glycolysis) 20, and fatty acids for fuel ( via β-oxidation)21 in response to energy demand. 
However, reduced lipid oxidation has been observed in the obese. Due to this decrease in lipid 
oxidation, it’s speculated that REE would be reduced. While skeletal muscle oxidative capacity 
was not measured in vitro within the present study other measurements such as VO2 max, resting 
and exercise respiratory exchange ratio, and near infrared spectroscopy was assessed to 
indirectly describe whole body substrate oxidation. 
 Substrate utilization was another component of interest with the present study. Substrate 
utilization is commonly measured by the RER through indirect calorimetry. Indirect calorimetry 
assesses the amount of carbon dioxide produced by oxidative metabolism, which requires 
oxygen consumption to drive ATP synthesis. The procedure of indirect calorimetry is expressed 
mathematically as the volume of carbon dioxide (VCO2) produced divided by the volume of 
oxygen (VO2) consumed required for mitochondrial respiration and ATP synthesis 22. The 
concept was first developed by Antoine Laurent Lavoisier 23, and his work made it possible to 
assess metabolic inflexibility toward substrate switching between the predominant energy supply 
(carbohydrate or lipid) in overweight or the obese population 11. Studies have shown that 
metabolic inflexibility is prominent in the obese and those who are insulin resistant, but the 
mechanism is still under investigation 12,18. It is unclear if metabolic inflexibility was developed 
after obesity or before. It is unknown if metabolic inflexibility contributes to obesity and/or 
insulin resistance. This is relevant in to the present study since both are associated with plasma 
lactate. Thus, the study of RER and its association with blood-lactate might aid identifying 
individuals who are predisposed or currently afflicted with metabolic disease notably in the non-
obese. The literature suggests the obese population has a different muscle metabolic profile than 




capacity follows 25. In this regard, a reduction in slow twitch oxidative, or Type I muscle fibers, 
was suggested to be one mitigating factor for reduced energy production from oxidative 
metabolism 19,26.  
When the body becomes less adaptive in using fat substrates, the reaction of glycolysis 
becomes more predominant in the anaerobic condition and proceeds to a greater pathway end 
product of lactate production 27,28. This altered energy production (shift from oxidative 
metabolism of carbohydrate as pyruvate) was commonly observed in individuals with significant 
differences in fat mass and fat free mass. In context of the obese population, REE adjusted to 
body weight, was significantly lower compared to their lean counter parts 29,30 . Lower REE was 
associated with lower levels of respiration of energy substrates (carbohydrates and lipids) leading 
to “forced” anaerobic metabolism as mentioned previously. The rise in lactic acid production 
was the concomitant result for anaerobic respiration. Thus, lactate may serve as a surrogate 
marker for reduced oxidative potential (via reduction in mitochondrial respiration) and a 
predisposition towards reduced aerobic energy production.  
 Collectively, metabolic diseases become more apparent with obesity 3,27. It was then 
reasonable to speculate that REE may be an indicator of a propensity or overt presence of the 
inability to generate sufficient energy aerobically. The result accompanied would be an elevation 
in plasma lactate production as the end product of anaerobic metabolism. As an outcome, it was 
predicted that the non-obese, predisposed to metabolic disease would also display a lower REE 
respective to elevated lactate concentration. This is a fundamental dependent variable (REE) to 
be assessed in the present project and forms a basis for the proposed hypothesis. Therefore, if our 




dysfunction of the aerobic capacity in individuals leading to an earlier phenotype manifested as 




 Our preliminary data (Fig. 1) showed a negative association between fatty acid oxidation 
and fasting lactate. We also showed a negative association between the resting blood plasma 
lactate and resting energy expenditure (Fig. 2). The current understanding of elevated lactate is 
due to characteristics that were related to reductions in aerobic metabolism of fuel substrate 
(carbohydrate and fatty acids) in obese individuals 31,17. An insulin resistance increase and lower 
aerobic capacity are both associated with lactate, and are prevalent in the obese population 10,32. 
These traits have also been noted recently in the non-obese 11,33.  
Figure 1. Correlation between fasting 
lactate and fatty acid oxidation in muscle 
homogenates of non-obese subjects. 
*Figure 2. Resting energy 
expenditure REE is high in 
subjects who have low plasma 
lactate. 
*Provided by Charles Tanner and his ECU students who collected the data 
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As supported from our preliminary data, there is a negative correlation between blood 
lactate and REE. In relation, plasma lactate is also negatively correlated with fatty acid 
oxidation. We believed that the non-obese who demonstrated elevated blood lactate levels (2.0 
mmol/L) were exhibiting lower energy expenditure before reaching the obese state. Therefore, 
plasma lactate and REE was studied to help us further understand energy production in these 
“pre-disposed” non-obese individuals.  
Research Question: 
Is there an association between blood lactate level and resting energy expenditure, and by 
extension aerobic capacity in young healthy non-obese females? 
Hypothesis: 
H0 : There is no association with plasma lactate and resting energy expenditure in non-
obese individuals.  
Ha: Resting blood levels is associated in reduction of energy expenditure in the non-
obese. To expand, higher plasma lactate level is associated with many metabolic diseases; REE 
would potentially be lowered due to a shift in energy substrate towards anaerobic respiration. 
Clinical Significance:  
Since a higher plasma lactate level is likely associated with many metabolic diseases such 
as obesity and Type 2 Diabetes, measurement of blood lactate levels may be used as an early 
predictor of a predisposal toward metabolic disease. The findings from this research project 
allowed for an economical diagnostic tool for clinicians to assess and/or predict metabolic 
disease and thus serve as an early treatment recommendation, thus allowing physicians to treat 





 The purpose of this study is to correlate blood plasma lactate level with resting energy 
expenditure (REE). 
Experimental Design 
 A total of 40 non-obese subjects were screened for the blood lactate. The lower (n=11) 
and higher (n=10) end of blood lactate spread were selected for further testing. Participants 
performed 20 min of indirect calorimetry to determine their REE. In addition, we assessed the 
metabolic response to a standardized aerobic exercise test to assess possible “inflexibility” in 
“substrate shifting” toward lipid versus carbohydrate. Furthermore, we obtained adjunct 
measurements of in vivo mitochondrial oxidation of substrate by near infrared spectroscopy 
(NIRS) to further correlate our data in plasma lactate and REE. We focused this investigation on 
non-obese subjects as preliminary data from our laboratories suggested that a dichotomy in 
resting energy expenditure exists even among non-obese individuals suggesting a “pre-
disposition” toward metabolic disease in non-obese individuals (suggested by BMI and body 
composition). 
Statistical Design 
Pearson product-moment correlation was used to measure the strength of the linear 
relationship between depend variables (resting energy expenditure, REE adjusted to FFM, BMI, 
body fat percentage, resting and exercise RER, absolute and adjusted to FFM VO2, oxygen 
utilization) and the predictor variable (lactate). Regression analysis provided the strength of 
association and predictive power (r2) of plasma lactate concentrations and each dependent 




High and Low Lactate groups. Two-way ANOVA was used to compare resting/exercise RER 
between groups and throughout time. 
 
Limitations: 
1. Error of the indirect calorimetry method to determine resting energy expenditure 
2. Age of the population 
3. Sample population from Greenville and surrounding area 
4. The degree of insulin resistance and metabolic flexibility 
5. Recruitment of lean subjects 
Delimitation 
1. Females 
2. Caucasian  
3. Random selection of subjects with a BMI between 18.5-26 kg/m2 
4. The duration of exercise indirect calorimetry 
5. Selected adult volunteers 
6. Level of daily physical activity among subjects as sedentary 
Operational Definition 
1. Body mass index (BMI): kg/m2 an index that classify an individual’s health risk. Normal: 
18.5-24.9, overweight: 25.0-29.9 kg/m2, obese class I: 30-34.9 kg/m2, obese class I: 35.0-
39.9 kg/m2, obese class III: >40.0 kg/m2. 
2. Obesity: excessive body fat that is beyond overweight, having BMI ranging from 30-34.9 




3. Metabolic flexibility: the ability to switch between two substrates, fat and carbohydrates, 
and its response to a change in availability  
4. Lactate: a product that yield from pyruvate by a redox reaction via enzyme lactate 
dehydrogenase (LDH) 
5. Insulin resistance: The blunted response of cells to insulin 
6. Type 2 Diabetes (Mellitus): chronic disease, which the cell becomes resistance to insulin 
and it, blunts the movement of glucose into the cells.  
7. Respiratory exchange ratio (RER): the ratio between the amount of carbon dioxide (CO2) 
produced in metabolism and oxygen (O2) used. The ratio is determined by comparing 
exhaled gases to room air 
8. Substrate: the reactant, which catalyze by the enzyme. In relevant of this, our substrate is 
our macronutrients (glucose and fat) 
9. Glycolysis: the metabolic pathway of breaking down glucose 
10. Adenosine Triphosphate (ATP): a complex organic compound that participates in many 
processes. Also known as the unit of currency of intracellular energy transfer. 
11. Indirect Calorimetry: technique that measures inspired and expired gas flow volumes and 
concentration of oxygen and carbon dioxide. 
12. Resting Energy Expenditure (REE): the amount of total energy that the body requires in a 
resting state 
13. Krebs Cycle (TCA: Tricarboxylic acid cycle): a series of chemical reaction used by all 
aerobic organisms to release stored energy through the oxidation of acetyl-CoA derived 
from carbohydrates, fats, and proteins into carbon dioxide and chemical energy in the 




Chapter II: Literature review 
Introduction 
 The purpose of the study was to investigate the potential association between resting 
energy expenditure (REE) and blood plasma lactate. It is important to note that our focus was not 
to measure metabolic inflexibility or insulin resistance. The following literature review contains 
the current knowledge of The Epidemic of Obesity, Lactate, Insulin Resistance/Type 2 Diabetes, 
and Skeletal Muscle, Metabolic Flexibility and Resting Energy Expenditure.  
The Epidemic of Obesity  
 Obesity is recognized by health professionals as one of biggest health epidemics in North 
America, USA 2. The estimated expenses that Americans spend on obesity treatment was 
between 147 to 210 million dollars annually 2.  To be specific, an average annual cost of 
treatment for an obese woman is around $4,879 and $2,646 for an obese man. If the epidemic 
continues, the cost for the U.S. alone could reach up to $580 billion dollars by year of 20307.  
 Obesity leads to a higher chance of developing other diseases, such as Type 2 Diabetes, 
hypertension, dyslipidemia, and cardiovascular disease. The risk for the development of these 
diseases is increased even more with a sedentary lifestyle 3. The consequences of obesity are 
severe as it’s strongly associated with diseases such as cardiovascular disease and cancer 34. A 
meta-analysis investigated the all-cause mortality rate across Australia, Asia, Europe, and North 
America. The study collectively analyzed BMI over 3.65 million individuals with no known 
chronic diseases with a 5 years follow up. The data showed the potential association between all-
cause mortality rate and BMI through the use of hazard ratio analysis, which consisted of 
participant/death of participants. This meta-analysis demonstrated the positive association of all-





 It’s commonly reported that obesity is negatively associated with aerobic capacity. 
Increased physical activity and exercise may help with weight management and improve aerobic 
capacity. Aerobic capacity is one of the strongest predictors of all-cause mortality and health 
related risk factors in men and women 36. Aerobic capacity is measured by oxidative capacity or 
volume of oxygen a person consumes for respiration (VO2). A Lancet study assessed the 
relationship of low oxidative capacity and mortality in normal, overweight, and obese men 35. 
The study observed over 25,000 men with a mortality follow up. The baseline of cardiovascular 
disease (CVD), Type 2 Diabetes, dyslipidemia, smoking, and low aerobic capacity was examined 
prior to the follow up. In the course of this study, a total of 1025 subjects were deceased, and 439 
deaths were due to CVD. Men who were either overweight or obese essentially had a greater risk 
of CVD and Type 2 Diabetes. This study highlighted that the obese group had the highest risk 
with 2.6 times higher risk for CVD and 1.9 times higher risk for all-cause mortality. The study 
concluded low aerobic capacity as a strong independent predictor of all-cause mortality, Type 2 
Diabetes, and other relative risk factors of CVD5.  
 Losing weight and sustaining a lower BMI by exercising can ultimately lower the risk of 
mortality 5,26. However, reducing energy intake and increase energy expenditure may be more 
difficult in people who are obese or overweight. Obesity has an inverse relationship with 
oxidative capacity 37, which is determined by aerobic respiration. The reduced content of 
oxidative, type I  fibers precedes a dependence on anaerobic respiration for energy demand, 
resulting in an increase of blood lactate 12,38. The elevation of blood lactate is a distinct feature in 
obesity. Insulin resistance and metabolic inflexibility are also characteristics that have been 
observed in obesity 18,19,27. This suggests there might an alteration in energy production from 
metabolic diseases.  
12 
We understand that obesity and other metabolic diseases carries negative physiological 
traits, and reduce the quality of life. The population of interest in our study was the non-obese, 
since the aerobic capacity of the non-obese has not been thoroughly studied along with lactate. 
Our question was that do people develop these metabolic alterations and then become obese or 
do they become obese and then developed disease traits? With obesity rate rising, studying the 
non-obese could potentially help in understanding the predisposition of obesity. 
Lactate (Adipose tissue and Lactate) 
Elevated plasma lactate level has been associated with many diseases such as obesity, 
insulin resistance, diabetes, hypertension, cardiovascular disease, and dyslipidemia 10,11,30,39,40.  
The etiology of lactate is mainly from metabolizing glucose substrate via glycolysis. The end 
product of glycolysis yields 2 moles of pyruvate, 2 NADH, and net of 2 ATP.  In the aerobic 
condition, pyruvate is translocated into the mitochondria by pyruvate translocase, and then 
converted to acetyl-CoA by a series of reactions to initiate the Krebs (TCA) Cycle38. However, 
in the anaerobic condition, pyruvate interacts with lactate dehydrogenase to yield lactate and 
NAD+ 24. Lactate is then transported to the liver to make glucose (via gluconeogenesis) to supply 
the nervous system and the red blood cells with energy substrate. In contrast, the surplus 
generated glucose can be converted and stored as glycogen via the process known as 
glycogenesis, but this does not occur in the catabolic condition such as during an overnight fast.  
Lactate in the blood can be produced by skeletal muscle, perivenous liver cells, red blood 
cells, adipose cells, and skin cells. Lactate that was produced would essentially get metabolized 
by various organs, with liver being the main contributor for disposing lactate. The liver accounts 
for 70% of lactate clearance in the blood, and the rest is being metabolized by the renal system, 
skeletal muscle, and cardiac myocytes24.  Under normal conditions basal lactate level is 0.5-1.0 
13 
mmol/L39 24, depending on the studies noted in the literature. Lactate concentration above 1.0 
mmol/L deviates from normal levels. However, elevated or high plasma lactate is not universally 
determined. Most studies have elevated lactate concentration marked as 2.0 to 2.5 mmol/L 39, 
and labeled >4.0mmol/L as “high”.  In the terms of glucose metabolism, people who have a 
lower basal blood lactate level are able to aerobically metabolize glucose, which would decrease 
the net basal lactate concentration. In most cases, elevated lactate concentration is an indication 
of a greater dependence on glucose for anaerobic metabolism due to attenuation of its oxidation 
of glucose.  
It was believed that adipose tissue contributes to a greater lactate concentration. 
Hagstrom et al. were the first to examine the role of adipose tissue toward lactate production in 
vivo. The study selected non-obese subjects and performed the microdialysis sampling technique 
within the subcutaneous adipose tissue after glucose injection. The dialysate determined there 
was an elevated level of pyruvate and lactate production that was independent from muscle 41. 
Previously, lactate production was believed to account for 1-3% of glucose uptake within the 
adipose tissue 31, but was later reconsidered to be more. It is estimated that lactate production is 
between 10-15% in  lean individuals, and 15% to >30% in the obese 31. Adipose tissue in the 
obese or diabetic state is able to uptake 50-70% of glucose, which has been shown in humans 
and mice31. This shows that extra adipose tissue in the obese is able to uptake more glucose in 
the blood and proceed to a greater lactate production. This may be the result in part from the 
reduction in muscle to aerobically utilize glucose, and subsequent to a greater conversion of 
glucose to lactate. Accordingly, adiposity has been associated with higher lactate production, and 
elevated lactate has shown to be more prominent with increasing BMI 10. The non-obese subjects 




their obese counterparts. This ruled out the potential lactate production from adipose tissue, as 
described from Hagstrom and colleagues. Poor aerobic capacity in the obese has been well 
documented 16,42. Decreased oxidative capacity would then be a better association factor for 
higher lactate production than adiposity in the present study.  
Skeletal Muscle in the Obese 
 Aside from extra adipose tissues, the obese also possess different muscle composition as 
one of the characteristics of reduced aerobic respiration. Skeletal muscle performs many 
biological processes, which metabolically requires high-energy demand. Skeletal muscle consists 
of two main phenotypes, Type I and II26. Type I are slow twitch fibers and are known for their 
high oxidative properties that require aerobic glycolysis to produce ATP. The energy system for 
slow oxidative fibers involve the mitochondria 38,43. Within the mitochondria, the process known 
as the Krebs Cycle or Tricarboxylic Cycle (TCA) is linked by mitochondrial derived pyruvate 
(from glucose) and beta-oxidation for lipid metabolism 33. The common molecule from 
glycolysis and/or β-oxidation is acetyl-CoA. Type II fibers are fast twitch and are more diverse 
with several subtypes (IIa, IIb, and IIx). The predominate energy pathway for type II fibers is 
anaerobic glycolysis to which the end product of is lactic acid which lactate is derived from. The 
aerobic Type I fibers produces acetyl-CoA derived from both glucose/pyruvate (instead of lactic 
acid) and fatty acids from mitochondrial β-oxidation. The amount of Type I fibers is a 
determining factor (although not exclusive; e.g., oxygenated blood deliver and O2 extraction) of 
an individual’s aerobic capacity 14,44.  
 Muscle phenotype is strongly associated with obesity. A greater fiber ratio favoring Type 
I muscle fibers has been shown to be reduced in the obese population 26. Tanner et al. examined 




group had a greater composition of Type I oxidative muscle fiber than the obese group. 
Conversely, the obese group had a higher composition of Type II anaerobic muscle fiber, and a 
lower Type I fiber content. The study suggested that there is a positive relationship between BMI 
and Type II muscle fibers, but inversely with oxidative capacity at the whole body level. 26 Other 
studies have concluded adiposity has much to do with the amount of slow oxidative Type I 
fibers45,46 as described briefly above.  The increasing amount of Type II fibers leads to elevated 
blood lactate during respiration10. This is due to the end product of glycolysis, pyruvate, which is 
unable to enter the mitochondria without the presence of oxygen. Therefore, compromising 
aerobic glycolysis, pyruvate is oxidized by lactate dehydrogenase (LDH) and converted to 
lactate. Lactate then gets transported to the liver to engage in gluconeogenesis to make glucose 
as mentioned above. At the whole body and cellular level, the ability to utilize oxygen is to a 
large extent  dependent on the amount of Type I fiber an individual possess26,45,46; this is 
metabolically related to greater content of mitochondria 43.   
Insulin Resistance/Type 2 Diabetes and Lactate 
 Elevation of lactate in obesity and insulin resistance  has been suggested in previous 
studies10,47. The inverse relationship was earlier established between insulin sensitivity and 
lactate production 10. Skeletal muscle and adipose tissues are both receptive to insulin, and high 
lactate concentrations have been observed in diabetics. Accordingly, in order to utilize glucose 
for fuel, insulin is required in tissues such as skeletal muscle (expanded upon below). Insulin’s 
function is to initiate aerobic glycolysis via stimulation of glucose uptake from the blood, 
followed by other regulatory proteins within the insulin signaling cascade 48. After glucose entry, 
cells begin to perform glycolysis for catalyzing glucose molecules for production of energy. In 




Cycle 38, also known as aerobic glycolysis. To expand, with the presence of oxygen, pyruvate 
bypasses lactate dehydrogenase (LDH), and enters the Krebs cycle to avoid lactate production. In 
the anaerobic condition, pyruvate undergoes an oxidation-reduction reaction resulting in the 
conversion to lactic acid 49.  
 Insulin is essential for the entry of glucose into the cell. Normally, insulin responds to the 
elevation of glucose, and amino acids10. Mechanistically, when glucose is present in the blood 
stream, it gets transported into pancreatic β-cells by the insulin independent GLUT 2 transporter 
protein. The transported glucose then gets phosphorylated and oxidized to generate ATP within 
the pancreas. The accumulation of ATP cause potassium channels to close and the β-cells to 
depolarize. The depolarization ensues via by an accumulation of intracellular calcium levels by 
the opening of the voltage sensitive calcium channels. The content of the insulin storing vesicles 
are then released to the blood stream via stimulated exocytosis following the increased level of 
intracellular calcium. Once the insulin is released into the blood stream, it binds to the cell 
surface receptors on sensitive tissues such as skeletal muscle and adipocytes. Thereafter, an 
insulin signaling cascade is stimulated to uptake glucose into the cell by facilitated diffusion. 
Glucose then would either be metabolized to ATP via glycolysis or stored as glycogen in the 
muscle50. In contrast, the hepatocytes (liver cell) are insulin independent with regards to glucose 
uptake51. When there is a positive energy balance (energy  surplus), the liver can become 
resistant to insulin at the intracellular level, notably in the inability to restrict gluconeogenesis 
(production of new glucose) 52. The clinical outcome is an exacerbated blood glucose content 
due to liver’s increased glucose production from uncontrolled gluconeogenesis, resulting in a 
hyperglycemic state in the blood (primary outcome in the diabetic state). In response, the 




become over-taxed to maintain normal blood glucose level, the body will reduce the ability of 
insulin to evoke the signaling cascade responsible for glucose uptake over. The prolonged 
excitation of pancreatic β-cells will sequence into hyperinsulinemia, the hallmark of the insulin 
resistant state and leading to an exacerbation of the  Type 2 Diabetic condition (concomitant 
hyperglycemia and hyperinsulinemia)18,53.  
 Insulin not only regulates blood glucose, but it also activates different kinases (JNK, 
PKC,mTOR, S6K, IKK, and ERK), and other enzyme cascades  (endothelin-1, free fatty acids, 
cytokines, amino acids, and cellular stress) that would phosphorylate the insulin receptor and its 
substrates48. These kinases and other signaling cascades specifically target insulin receptor 
substrate-1 (IRS-1), which is associated with insulin resistance (i.e., insulin receptor tyrosine 
kinase activity and downstream signaling). With phosphorylation of specific serine residues on 
IRS-1, the body reduces the ability of insulin to evoke the signaling cascade responsible for 
glucose uptake. If not treated, insulin resistance would be induced to leading eventually to Type 
2 Diabetes (hyperglycemia and “forced” hyperinsulinemia) 11.  
 As noted, hyperinsulinemia contributes to insulin resistant and potentially leads to Type 2 
Diabetes. Fasting insulin level increase with obesity 54. Evidence suggests the accumulation of 
intramuscular lipid may be part of the reason for provoked insulin resistance 53,55–57. In addition, 
studies have shown an inverse relationship between plasma FFA and insulin sensitivity. 
Accordingly, an accumulation of intracellular FFA (so-called bioactive FFA such as diacylerol 
glycerol and ceramides) are associated with an inhibition of IRS-158. These observations direct 
an alteration of insulin-activated glucose transport and subsequently phosphorylation of IRS-1 
commonly found in the obese and individuals with Type 2 Diabetes 48. For this reason, we were 
interested in looking at the blood analytes of insulin and glucose concentration in our non-obese 
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subjects to draw association with lactate. We investigated insulin and lactate concentration to 
potentially explain the association of lactate and REE. 
To summarize, the pancreas accommodates the reduction in insulin stimulated glucose 
uptake by secreting more insulin to the blood, subject to the induced hyperglycemia. Over time, 
the pancreas becomes “worn out” and stops secreting appropriate amounts of insulin. The result 
is  clinically presented as the development of Type 2 Diabetes 59. In this regard, skeletal muscle 
is the largest insulin dependent tissue in the body by weight and hence responsible to clear ~85% 
of blood glucose following a meal60The unifying theory is that Type 2 Diabetes exhibits higher-
levels of blood lactate11. We were interested in observing the glucose and insulin levels that 
correspond to the recruited subject’s lactate level. Investigating REE (see immediately below) 
and its relations with lactate would better help to understand glucose/insulin action in subjects 
who may be predispose to metabolic diseases (clinically for the early detection of metabolic 
diseases such as obesity and Type 2 Diabetes).  
Resting Energy Expenditure 
Knowing the alteration of metabolism with obesity, it is essential to understand energy 
expenditure. As first described by the French chemist Antoine Laurent Lavoisier, the metabolic 
energy transformation involving oxygen consumption and carbon dioxide production can be used 
to determine energetic requirements. The muscle constantly synthesizes ATP, and the energy 
requirement at rest accounts for a great amount of the daily energy demand. The demand for 
ATP at rest is referred as the resting energy expenditure (REE), which is commonly measured by 
indirect calorimetry. Accumulated evidence suggests the existing lean mass is a major 
determining factor accounting for daily energy requirements.  
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Studies on energy production vary across obese populations 49,61. There are conflicting 
data between REE and obesity. The obese was shown to have either a lower, or no difference in 
REE when adjusted to their fat free mass (FFM)62. The studies that showed no association 
between the two did not consider metabolic disease as a factor. Other  studies however, do 
suggest a negative correlation between obesity and REE61,63. The difference of a lower REE 
could be an early sign of the development of metabolic diseases. Obesity is associated with an 
alteration in metabolic processes that correlate with the inability to oxidize fat in skeletal muscle, 
precipitating insulin resistance, and impaired metabolic flexibility 18,19,27,64, which can be 
explained in part by a lower REE. Obese individuals who showed no difference in lowered REE, 
may have yet to develop metabolic diseases, which demonstrated no variance in REE from 
disrupted energy production. Concurrent with these studies, blood lactate has become an interest 
that corresponds with metabolic dysregulation specifically reflective of necessitated 
enhancement of anaerobic respiration due to reduction in oxidative capacity of all substrates 
10,11,46,61. Blood lactate has been studied in conjunction with obesity and obesity related health 
conditions. However, REE and lactate have not been thoroughly investigated. The main purpose 
of this study is to test for the potential relationship between REE and blood lactate.  
As stated, skeletal muscle tissue is a major determining  factor in energy expenditure37, 
due to the fact that it has a high turnover rate of ATP. Measuring resting energy expenditure 
(REE) is a useful assessment for weight control. As alluded to above, the REE contributes to 50-
75% of total energy expenditure65. As stated before, indirect calorimetry is reputably accurate 
and it is an non-invasive method in retrieve REE and RER66 67 68.  
In some studies, REE has been shown to have a positive correlation with BMI between 




account for both fat mass (FM) and fat free mass (FFM) independently. According to Kleiber, 
basal energy expenditure corresponds to three quarters of the body weight69. Kleiber proposed 
that with an increase of the total adipose tissue, muscle mass would subsequently increase due to 
the energy demand for the excess fat. Therefore, REE would increase, displaying a positive 
correlation between the two. This could explain why in some studies REE has a positive 
association when adjusted to FFM62. In contrast, other studies have suggested that the increase in 
muscle mass to positive REE has its limitation70,71, and that there was no association in adjusted 
REE in obese and non-obese. The reasoning is that the mass of excess adipose would eventually 
dilute the contributions from the lean mass. Both sets of data were conflicting. However, they 
were not specific among subject samples examined. Throughout these studies, metabolic activity 
of the FFM, such as oxidative capacity, was not considered. The conclusion from these studies is 
that strongly associates between BMI, and tissue composition may result in the human metabolic 
variation across obesity. 
 In the present study, we hypothesized that the REE would decrease as fasting lactate 
increases. Although lean tissue is the determinant factor in energy expenditure, it may vary 
depending on the type of lean tissue. FFM consists of bones, skeletal muscles, and smooth 
muscles. Each are individualized in their contributions to metabolic activity, with skeletal muscle 
being the greatest contributing tissue. Even within the skeletal muscle however, oxidative fibers 
affect energy production as discussed 37,72. 
To expand, metabolism systematically varies across the levels of obesity. For example, 
Heymsfield et al. examined adjusted REE and FFM differently from previous studies. In their 
findings, magnetic resonance imaging (MRI) was used to supplement adjusted body composition 




(FFM) components. Four types of FFM were obtained in this study: 1) low-metabolic-rate fat-
free adipose tissue (18.8 kJ/kg), 2) skeletal muscle (54.4 kJ/kg), 3) bone (9.6 kJ/kg), and 4) 
residual mass (225.9 kJ/kg).  The thermogenesis value for the FFM was then combined with 
body composition to correlate with REE. The reported result of REE from this study was 
negatively correlated with adjusted FFM. This was a better representation of computing REE and 
FFM than the studies that were mentioned in the beginning. They accounted for metabolic 
activity in different regions of the FFM, which previous studies ignored. 
 In addition, other metabolic alterations may also affect REE. People who are exposed to 
insulin resistance and metabolic inflexibility present a lower REE. Adamska-Patruno et al. 
investigated the effects of postprandial REE and substrate utilization in normal and obese 
subjects 61. When given high carbohydrate meals, glucose utilization corresponded accordingly 
to the amount of available substrate in both groups. Glucose utilization was higher when given 
high carbohydrate meals compared to normal carbohydrate meals. However, the normal group 
represented a higher level of glucose utilization and at a faster rate than the overweight/obese 
group. In contrast, fat oxidation level was respectively opposed to glucose oxidation. When the 
subjects were introduced to high fat meals, both groups showed an increase of fat oxidation, but 
the rate of fat oxidation were slower and lower in overweight/obese group than the normal group. 
With respect to REE in these studies, both groups showed an increase in postprandial REE, but it 
was notably lower in the obese/overweight than the normal group. The overweight/obese group 
had a lower fasting and postprandial REE than the normal group. The outcome of this study 
demonstrated that overweight/obese group had a slower time adapting to the available substrates, 
and a lower fasting and postprandial REE. The author described the obese/weight group as 




 Thus, in the obese population, a lower REE is observed, perhaps related to the presence 
of metabolic disease. This may cause metabolic alterations in the cell which affect mitochondrial 
function. This can result in secondary effect to conversion of Type II muscle fiber. As stated, 
Type II muscle fibers are lactate producers due to the reliance on glycolytic anaerobic 
metabolism. We contend that a lower REE would be reflective of a higher lactic acid generation 
potential and a lower oxidative capacity 45.  
Metabolic Flexibility and Energy Expenditure 
 Although not directly measured in the present research design, it is important for the 
reader to have an underlying concept of substrate switching in the normal physiological state. 
Metabolic flexibility is defined as the capacity by which the body can adapt fuel oxidation to 
match fuel availability. The two primary fuels that the body utilizes are carbohydrates (glucose) 
and fats (fatty acids). Cells metabolize both glucose and fatty acids for energy; flexibility 
becomes impaired when the body cannot shift between the two available substrates 16,18,73. 
Research has shown that metabolic inflexibility is displayed in people who cannot adapt to the 
available substrates whether a predominance of carbohydrate or lipids 73. These individuals also 
have an accelerated rate of hepatic gluconeogenesis to compensate for a lack of fat utilization 31. 
This metabolic alteration is associated with elevated lactate compare to someone who can switch 
substrate utilization, or metabolically flexible. The etiology of metabolic inflexibility is still 
unknown;  74however, obesity and insulin resistance are associated 18,73,75.To measure substrate 
ratio utilization of carbohydrate and lipid fuel sources, indirect calorimetry is considered to be 
one of the best methods at the whole body level to assess the cells ability to accommodate 
substrate flux due to its non-invasiveness and precise estimation of substrate oxidation 66,67. The 




and oxygen measurements with a metabolic cart) would compute the respiratory exchange rate 
(RER). RER indicates the amount of carbon dioxide being expired as the result of substrate 
oxidation in the mitochondria, divided by the amount of oxygen being consumed required for 
oxidative metabolism by the electron transport chain (VCO2/VO2)19. The RER serves as an 
indirect measurement on cellular substrate utilization.    
 There are many studies that implicate metabolic inflexibility in fuel oxidation associated 
with obesity and insulin resistance 8,15,76,77. The origin and underlying mechanism of metabolic 
inflexibility is still speculative. It is unclear if one develops the condition before or after they’ve 
become obese. It is believed that most would ultimately degrade to some degree of metabolic 
inflexibility without intervention. One study found RER and oxidative capacity to be positively 
associated with fat mass in sedentary premenopausal women78.  The subjects that were included 
in the study were overweight to Class 1 obesity. This suggested the mitochondria within those 
women were aerobically functional, and responded accordingly to the amount of fat they 
possessed despite being overweight or obese. It is important for us to study lactate as we 
rationalized elevated lactate is the result of lower oxidative capacity. The reduction in glucose 
uptake by the cell reduced oxidative phosphorylation is associated with metabolic inflexibility, 
which would eventually exacerbate the development obesity and diabetes. With regards to the 
present study, we indirectly emphasized another suspected mitigating factor leading to metabolic 
diseases; the reduction in glucose and lipid oxidation due to compromised mitochondrial 
capacity. The end result is that the cell is being forced to generate energy solely by anaerobic-





 The purpose of this study is to determine if plasma lactate can be a predictive tool in 
measuring resting energy expenditure (REE). Due to many aspects of obesity leading to 
metabolic disease, it is speculated that plasma lactate may be indicative of a predisposition 
toward an inability to generate energy aerobically. The implied concomitant result is an elevation 
in lactate production as the end product of anaerobic metabolism that leads to elevations in 
plasma lactate concentrations. The hypothesis entertained currently is a reduced oxidative 
capacity leading to heightened anaerobic metabolism of carbohydrate due to the inability to 





Chapter III: Methods  
Subjects 
 A total of 40 subjects were recruited from East Carolina University and Greenville area. 
All subjects were Caucasian non-obese females. Subjects’ age ranged from 18 to 26, BMI ranged 
from 18.17- 25.9, and none were diagnosed with metabolic or heart disease. From the 41 
subjects, the top (n=10) and bottom (n=11) of the 40 subjects pre-screened for resting blood 
lactate levels was selected for further testing. Each of the subjects were non-smokers, showed no 
physical impairment to exercise, non-pregnant, no known cardiovascular or metabolic diseases, 
and were not currently enrolled in a diet or supervised exercise program.  
Instrumentation 
 To screen for plasma lactate concentrations, a sterile lancet was used to prick the finger in 
order to draw the blood droplet sample. A lactate test strip was used to collect the blood droplet 
and acquire a lactate reading, which was analyzed by a lactate meter (Lactate Plus, Waltham, 
MA) device. Resting heart rate was recorded using a Polar heart rate monitor (Kempele, Finland) 
baseline fingertip pulse oximeter (Fabrication Enterprises, Elmsford, NY), and blood pressure 
was assessed manually using a mobile sphygmomanometer (Welch Allyn, Skaneateles Falls, 
NY) and a stethoscope (Littmann, USA). For the measurement of REE and the respiratory 
exchange ratio (VCO2/VO2,), Parvo Medic’s True 2400 metabolic cart (East Sandy, UT) was 
used for indirect calorimetry. The metabolic measurement software within the Parvo metabolic 
cart analyzed the O2 and CO2 flow/volume ration. Dual-energy X-ray absorptiometry (DEXA; 
Horizon, Danbury, CT) scanner was used to analyze the subject’s body composition. An 
Excalibur Sports cycle ergometer (Lode, Netherlands) was used for the modality of exercise and 





instrument was used to determine the recovery rate of muscle VO2 (mVO2) saturation as an 
indirect measurement of oxidative capacity. Blood analysis was determined by using a 
hematology analyzer (Beckman Coulter, USA).  
Measurements Protocol 
Screening: 
After subjects responded to posted advertisements, prescreening was conducted through 
the phone or email to determine if all the inclusion criteria were met. The qualified participants 
were then scheduled to come into the Human Performance Lab/FITT building at East Carolina 
University. Subjects were asked to arrive in a fasted state, which consisted of refraining from any 
exercise for three days, food, stimulants (caffeine, nicotine, stimulant medication, and etc.), and 
alcohol for at least 10-12 hours. Upon arrival, informed consent was obtained by IRB approved 
study staff (verbally and in writing) and signed by each subject prior to the experiment. 
Participants were also asked to complete the IRB approved personal family history form, a 
physical activity questionnaire, DEXA radiation consent form, and menstrual cycle questionnaire 
prior to REE measurement and VO2 max test. 
 Upon subject’s arrival, weight (kg) and height (m) was first obtained for BMI.  Resting 
heart rate was recorded using a finger pulse oximeter, and blood pressure was assessed manually 
using a mobile sphygmomanometer and a stethoscope. Lactate was then obtained by using the 
Lactate meter for blood lactate assessment. Lactate Plus has been shown to provide reliable and 
accurate readings of blood lactate when compared to laboratory-based analyzers 79. When ready, 
the third finger or the “ring” finger of the non-dominant hand was selected for the lactate 




use lancet needle was used to penetrate the skin of the fingertip for venous blood exposure. 
Blood was retrieved with a lactate strip and inserted into the Lactate Plus for measurement. 
Blood lactate was analyzed twice to ensure lactate values were within 0.3 mmol/L. If there was a 
difference between the two readings that is greater than 0.3 mmol/L, an extra lactate 
measurement was obtained with a value within 0.3 mmol/L of the last measurement. In the case 
of lactate meter error readings, measurement was obtained again. Sterile gauze was used to wipe 
off any excessive blood on the finger, and a bandage was applied to cover up the wound upon the 
completion of lactate analysis.  
First Visiting Day    
 For the subject: A copy of food diary was sent to the subject 7 days in advance to be 
completed prior in coming in on the scheduled day. Prior to arrival, subjects were instructed to 
remain in the fasted state for 10-12 hours. Subjects were encouraged to ceased eating after 10:00 
PM the night before.  
 During the visit: On this day, subjects’ body composition, REE, blood draw, and their 
VO2 max was assessed. Upon arrival, subjects’ resting heart rate was recorded using a Baseline 
Fingertip pulse oximeter, and blood pressure was measured manually using a 
sphygmomanometer and a stethoscope. Dual-energy X-ray absorptiometry (Horizon, Danbury, 
CT) or DEXA scan was performed first to assess subject’s body composition.  
 Body composition was assessed using the DEXA scanner. In preparation for the scan, the 
study staff reviewed for safety precautions such as no metallic jewelry, and with minimal chance 
of pregnancy. The subjects were then correctly aligned on the bed of the DEXA scanner. The 




end of the bed. A Velcro strap was used to wrap the subjects’ feet together. The limbs of the 
subject were checked to ensure they were within the marked parameter of the bed. The scan 
started after confirmation of the subjects’ correct positioning; the subjects were instructed to stay 
still and minimize any movement. The scan lasted approximately two minutes and 30 seconds 
for all participants. After the scan was completed, the results were acquired. 
 Upon completion of the DEXA scan, a REE test was performed. During the REE 
assessment, subjects were seated for 20-30 minutes in a quiet room where the assessment took 
place. The environment of the testing room was temperature-controlled at around 70 °F (21 °C). 
A desk lamp was dimmed for the room to provide a relaxed setting to help the subject to adjust 
to the resting state. The subjects were reminded to stay awake and minimize movement before 
initiating the REE assessment. Once the subject rested for 20-30 minutes, an open circuit canopy 
hood was equipped for REE measurement via indirect calorimetry for a 20-minute measurement. 
CO2 levels were adjusted in the canopy and stabilized as close to 1.0% as possible.  Throughout 
the REE measurement, the subject was left alone in the testing room, and was periodically 
monitored every 5 minutes through an open door. CO2 levels through the canopy were also 
monitored closely and adjusted if it necessary through that 5-minute check-up. The test was 
terminated after 20 minutes of successful measurement. Equipment was detached from the 
subject, and the REE test results were acquired from the metabolic cart.  
 Upon completing the REE assessment, a VO2 max test was performed via a cycle graded 
exercise protocol. Indirect calorimetry technique was used to obtain aerobic capacity and 
exercise RER. Before the VO2 max test, procedures were explained to the participants, and the 
seat was adjusted for subjects’ comfort. A mouthpiece and a headgear were fitted to subject’s 




rate, and was manually recorded by hand. Subjects resting heart rate and blood pressure were 
also measured.  Before the start of the test, subjects were encouraged to exercise as long as they 
can. At the start of the test, a baseline of gas exchange was established on the metabolic cart. The 
workload on the bike was preprogrammed to automatically enter each stage. The participant was 
informed to pedal at a comfortable frequency, or at a frequency between 50-70 revolutions per 
minute. A 10 second warning was given to the participant before entering a new stage. At the 
end of each stage, RPE and heart rate was recorded. Blood pressure was recorded at the end of 
the first stage and then every other stage. Subjects progressed through each stage until maximum 
effort was achieved, or subjects fell below 40 revolutions per minute on the cycle ergometer. All 
subjects reached a max status by meeting at least 2 of the following criteria: 1) RER ratio of 
1.10, 2) RPE above 17 on the Borg scale, and 3) peak heart rate within +/- 5% of max heart rate 
(using age predicted formula, 220-Age). Upon successful completion of the test, heart rate and 
blood pressure was recorded immediately, as the subject entered the active recovery phase. 
During active recovery, the load of the cycle was set to zero watts, and was adjusted to the 
comfort of the subject if needed. Heart rate was recorded every minute, and blood pressure was 
recorded every 2 minutes to monitor normal hemodynamics response. The test was terminated 
when a normal hemodynamic response was observed, and subject’s heart rate and blood is close 












1 1 30 
2  30 
3 2 60 
4  60 
5 3 90 
6  90 
7 4 120 
8  120 
9 5 150 
10  150 
11 6 180 
12  180 
13 7 210 
14  210 
15 8 240 
16  240 
17 9 270 
18  270 
19 10 300 





Second Visiting Day 
For the experimenter: A metabolic cart was turned on, and calibrated for at least 30 
minutes prior to subject’s arrival. The computer and the OxiplexTS were turned on for at least 20 
minutes before taking any measurements. During this time, the 2 independent data acquisition 
channels (probe) equipped with the OxiplexTS was calibrated. The 15-gallon air compressor 
(Model D55168, Dewalt, Baltimore, MD) was set to 30 psi to control the blood pressure cuff. 
Polar Electro heart rate sensor/watch, baseline fingertip pulse oximeter, sphygmomanometer, and 
a stethoscope were gathered in place for heart rate, and blood pressure measurements.  
For the subjects: All test subjects were reminded to be in a fasted state for at least 10-12 
hours, and refrain from any physical activity for at least 48 hours. Subjects were also reminded to 
eliminate stimulants for 12 hours, and alcohol for 24 hours before the second visiting day. The 
subject was directed to wear comfortable athletic wear.  
 During the visit: On day two of testing day, blood draw, near infrared spectroscopy 
(NIRS) measurement and a submaximal exercise session were conducted. A total of three 5 mL 
(Mel or approximately 3 teaspoons) of blood sample were collected via a venipuncture and 
sterile butterfly by one of the research staff. To prevent cross contamination, 5 mL of the “red 
top” evacuated collection tube was attached to draw the blood first. Then, a 5 mL blood sample 
of “purple top” evacuated collection tube, and a 5 mL blood sample of “purple top” with DPPIV 
inhibitors evacuated collection tube was collected. After each tube is filled with blood, the 
samples were immediately spun down in a centrifuge, and each was aliquoted into two cryovials. 
The purple top without the DPPIV inhibitor blood sample was analyzed using a hematology 
analyzer (Beckman-Coulter, USA) for fasting glucose, insulin, and lactate. The red top and 




 The NIRS measurement followed the blood draw. The NIRS protocol is a non-invasive 
method of assessing mitochondrial respiratory capacity at the whole body level. The NIRS 
probes consisted of 8 infrared diode lasers (four emitting at 691 nm and four at 830 nm) and a 
detector within each (emitter-detector distances 2.0-4.0 cm) was secured to the vastus lateralis 
belly of the dominant leg using a double-sided adhesive tape and Velcro straps. To prep for the 
NIRS assessment, a skinfold caliper (Lange, Beta Technology, Santa Cruz, CA) was used to 
measure subcutaneous adipose tissue thickness at the probe site (~10 cm above the patella). This 
was used to determine which probe to use as each probe is set to measure mVO2 dependent on 
the subcutaneous fat. Probe B was used for individuals with skinfold of 30 mm or less, and probe 
A was used for individuals with skinfold greater than 30 mm. For each NIRS measurement, 
participants were positioned supine on a medical examination table with both legs fully 
extended. After the correct probe was selected, blood occlusion was then initiated. A blood 
pressure cuff was placed as high as anatomically possible, and ensured the NIRS probe is outside 
contact of the cuff after inflation. A 15-gallon air compressor was set to 30 psi and was used to 
control the blood pressure cuff. Upon securing the probe, three 5-second practice occlusions 
were done to ensure subjects were familiar with the pressure around their leg, and making sure 
there was no pinching on the participants’ leg. The first arterial occlusion was the baseline 
measurement, where participants completed a 60 second duration of occlusion. Subjects were 
rested for 2-3 minutes before the second occlusion. After resting, isometric contraction of the 
quadriceps was performed for 15-20 seconds. Following isocontraction, the cuff was inflated for 
the second arterial occlusion (300 mmHg) for 5 minutes to determine the total deoxygenated 
hemoglobin (deoxy Hb). The collected data was then processed, and the rate of deoxy Hb was 




total deoxy Hb oxygen kinetics obtained from the 5-minute. Percent-deoxy Hb was then 
calculated by taking rate of deoxy Hb dividing the total deoxy Hb (umol/minute).  
 The submaximal exercise portion of the experiment was followed upon completion of 
NIRS measurement. The submaximal exercise test was conducted on the Excalibur Sport cycle 
ergometer for 20 minutes. The intensity of the exercise was set to 50% of their VO2 max 
obtained from the 1st visit, and exercise RER was collected via indirect calorimetry. In preparing 
for the submaximal exercise test, subjects were equipped with Polar Electro heart rate sensor and 
Polar Electro watch to assess their heart rate. The cycle ergometer was adjusted to the 
participants’ comfort with headgear and the mouthpiece secured. The metabolic cart assessed for 
VO2 baseline, while the subject was instructed to cycle at a workload that matched their 50% of 
their VO2 peak. Adjusting workload for the participants took approximately 2-3 minutes. 
Subjects were instructed to pedal at a comfortable frequency, and that was 50-70 RPM range to 
maintain consistency. Subjects cycled for 20-minute in duration while maintaining 50% of their 
VO2 max. Exercise heart rate was recorded at the end of every minute. A baseline fingertip pulse 
oximeter was used as backup for assessing heart rate. Throughout the exercise, subject was 
monitored to ensure the participant is exercising at the given rate. Upon completion of the test, 
the load of the cycle was lowered to the comfort of the participant. Hemodynamics was 
monitored to ensure subject’s safety. After the submaximal exercise test, data was acquired from 
the metabolic cart for subject records and stored in a locked file cabinet located in a secure room 







 BMI was calculated by dividing the subject’s weight over height squared (kg.m2). Out of 
the 40 subjects of the screening process, only the top (n=10) and bottom (n=11) quarter from the 
lactate spread was selected for further testing. Subjects’ exercise energy expenditure, and both 
resting and exercise RER from indirect calorimetry was collected from the metabolic cart. The 
DEXA scanner provide body composition which consisted of Fat mass (FM) and Fat Free Mass 
(FFM). FFM from the DEXA was used to adjust participant’s REE in kcal/kg of FFM/day. 
Blood samples were collected in the order of red top, purple top, and purple top with DPPIV 
inhibitors. Beckman-Coulter hematology analyzer was used to determine the concentration of 
fasting insulin, glucose, and lactate then processed Blood samples. The oxygen utilization was 
obtained from the NIRS analysis and was processed manually using Microsoft Excel.  
Screening
•Height and weight
•Personal history form, activity questionaire, mentrual cycle questionaire 
•40 Lactate Stick 
•(Top 10 and bottom 10 was selected for further testing)
First Visit
•DXA Scan
•Resting Energy Expenditure Test 
•VO2 Max Test 
Second Visit
•Blood draw 
•Near Infrared Spectroscopy 





 To determine the relationship between lactate and REE (adjusted to their lean mass), 
Pearson product-moment correlation was used to measure the strength of the association between 
the variables of plasma lactate and REE in High and Low Lactate group. Furthermore, BMI, 
REE (adjusted to lean mass), resting RER, exercise RER, mVO2 data was analyzed individually 
with plasma lactate for strength of association using the Pearson Product-moment correlation. In 
addition, an unpaired two sample T-test was used to analyze the high and low plasma lactate 
group for REE (adjusted to lean mass), resting RER, exercise RER, mVO2, fasting insulin and 
fasting glucose to determine the level of statistical significance. The statistical significance was 
set a priori at a probability level of P < 0.05.  
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Chapter IV: Results 
Subjects 
All subjects (n=40) recruited were non-obese, with no known cardiovascular or metabolic 
diseases. Subjects with higher (n=10) and lower (n=11) blood lactate concentration were 
categorized as High and Low Lactate groups respectively, and were further studied.  Both High 
and Low Lactate groups were similar in age (22.5±0.68, 21.21±0.58 year), height (1.656±0.02, 
1.82±0.02 m), weight (60.05±2.06, 64.37±1.30 kg), BMI (21.91±0.69, 22.82±0.62 kg/m2), total 
fat mass (19.65±1.54, 21.25±0.99 kg), and total fat free mass (41.13±1.15, 43.69±1.203 kg) 
respectively. However, relative body fat percentage was significantly higher in the Low Lactate 
Group (P<0.05). Laboratory blood characteristics of lactate (0.8578±0.0721, 0.7391±0.1478 
mmol/L), insulin (4.271±0.5162, 5.167±0.5605 uIU/mL) glucose (90.77±1.351, 88.26±1.335), 
and HOMA-IR (0.9505±0.1094, 1.135±0.1293) were also respectively similar between High and 




Table 1. Participant’s Characteristics 
 









Age (year) 21.21 ± 0.58 22.5 ± 0.68   
Height (m) 1.682 ± 0.02 1.656 ± 0.02   
Weight (kg) 64.37 ± 1.30 60.05 ± 2.06   
BMI (kg/m2) 22.82 ± 0.62 21.91 ± 0.69   
Lactate Conc. (mmol/L) 0.52 ±0.02 1.20 ±0.11   
Body Fat (%)  32.72±1.27 28.92±1.22  *0.0442 a 
Total Fat Mass (kg) 21.25±0.99 19.65±1.54  0.2512 a 
Total Fat Free Mass (kg) 43.69±1.203 41.13±1.15  0.1971 a 
REE (kcal) 1294±52.52 1290±28.47  0.9725 a 





Resting RER (VO2/VCO2)  0.8182±0.02 0.831±0.18 




Exercise RER (VO2/VCO2) 0.8003±0.02 0.8317±0.02 
 0.2041 a 
*<0.0001 b 
 
Absolute VO2 (L/min) 1.99± 0.09 1.844 ± 0.10 
 0.2899 a 
0.1961 c 
 
Relative VO2 max (mL/kg/min) 30.83±1.23 27.7±1.75  0.1540 
a 
0.1169 c 
Adjusted Relative VO2 max  
(mL/kg lean mass/min) 67.55± 3.35 44.76± 2.02 
  
*<0.0001 a 
*  0.0002 d 
 
NIRS Aerobic Capacity (%) 35.38 ±4.20 27.69±3.53 
 0.1815 a 
0.3891 c 
 
ΔRER    *0.0466 c 
Data are expressed as mean ± SEM for Low Lactate Group (n=11), High Lactate Group (n=10); 
age, height, weight, BMI (Body Mass Index), lactate concentration, body fat percentage, total fat 




exchange ratio (RER), Absolute VO2 max, relative VO2 max (mL/kg/min), adjusted Relative 
VO2 max (mL/kg lean mass/min). * Significance P<0.05.  
 
a  Unpaired t-test between groups 
b  2-way ANOVA 
c  regression for the High Lactate group 
d regression for both Group 
 








Lactate (mmol/L) 0.7391±0.1478 0.8578±0.0721 0.1628 a 
Insulin (uIU/mL) 5.167±0.5605 4.271±0.5162 0.2637 a 
Glucose mg/dL 88.26±1.335 90.77±1.351 0.2072 a 
HOMA-IR 1.135±0.1293 0.9505±0.1094 0.3021 a 
Data are express as mean ±SEM for Low (n=11) and High (n=9) Lactate Group for Lactate, 
insulin, glucose, and HOMA-IR. 






Figure 1. Lactate Concentration (mmol/L). Data is presented with number of participants, and 
a 5 number summary of each group as minimum, Q1, median, Q3, and maximum for: High 
(n=10, min=0.85, Q1=0.925, med=1.25, Q3=1.5, max=1.8, Spread=0.95 mmol/L), Low (n=11, 
min=0.40, Q1=0.50, med=0.55, Q3=0.55, max=0.55, Spread=0.15 mmol/L), Overall (n=40, 
min=0.40, Q1=0.55, med=0.55, Q3=1.025, max=1.80, spread=0.95 mmol/L) 
 
Lactate and Body Composition 
 Lactate and BMI was compared between the High and Low Lactate group (Fig. 1). The 
correlation coefficient was reported to be r = 0.01035 for the High Lactate Group (r2=0.0001), 











Figure 3. Body fat percentage (BF%)  
* Significance P<0.05 
 
 Body composition was analyzed in both High and Low Lactate Group by using the 




test was performed.  There was a significant difference between High and Low Lactate Group 




Figure 4.  Lactate and REE.  
 
 
Figure 5. Lactate and REE.  
 
Resting Energy Expenditure and Lactate 
 REE of High (n-10) and Low (n=11) Lactate group were measured for 20 minutes over a 




in all participants in computing REE. REE was then compared to lactate concentration using 
Pearson Product Moment Correlational Analyses (Fig. 4). The subjects from the High Lactate 
Group (=9) were shown to have R= -0.6093, and r2=0.3712. The Low Lactate Group (n=11) 
with R=0.2822, and r2=0.07963. Linear regression line was fitted in High Lactate Groups. No 
significance was found in Low (P=0.4005), High (P=0.06015) Lactate groups. No significant 
difference was found when REE was compared using unpaired two sample t-test. 
 
 
Figure 6.  Lactate and Adjusted REE. REE was adjusted to the subject’s lean body mass 
represented as mL/kg of FFM/min.  









Figure 7. Lactate and REE.  
 
REE of High (n=9) and Low (n=11) Lactate group were adjusted to the participant’s 
FFM (Fig.6). One outlier was detected 2 standard deviations above the mean in the High Lactate 
Group, and was excluded from the analysis. Pearson Product Moment Analysis, and a line of 
regression were used to determine the association and significance between lactate and adjusted 
REE. REE adjusted for FFM demonstrated a strong association in High (r2=0.4656) Lactate 
group, with significance (P=0.0429). No significant difference found in adjusted REE between 






Figure 8. Lactate and Resting Respiratory Exchange Ratio (RER)  
 
Resting Respiratory Exchange Ratio (RER) 
 Resting RER was measured concurrently with the REE assessment (Fig. 8). Using 
Pearson Product and regression analysis, High Lactate Group demonstrated  a strong correlation 
coefficient of correlation with R=0.6295, and r2=0.3963 (P=0.05).  
 
 
Figure 9. Resting RER and Overall time. Time points are represented as mean ± SEM within 





Respiratory Exchange Ratio Overall Time 
 Resting RER of High (n=9) and Low (n=11) Lactate group was ploted across time as 
represented (Figure 9). Resting RER is the same data set from acquired from resting REE. 
Measurements of resting RER for one subject were lost in the High Lactate Group. Resting RER 
data collection depicts a PRE phase, minute 0, 5, 10, 15 and 20. The PRE stage depicts subjects 
being acclimated before the 20 minute measurement. Resting RER at minute 0 to 20 represents 
the average RER of the given group after reaching steady. A two-way ANOVA was used to 
compare the potentia for significant differences of RER between groups at each time point, RER 
of both groups at each time point, and RER within the group at each time point. Resting RER 




Figure 10. Exercise RER and Overall time. Time points are represented as mean ± SEM 







Exercise RER of High (n=10) and Low (n=11) Lactate group was ploted across time as 
represented in Figure. 10. All subjects’ exercise RER was determined by 20 minute low intensity 
(50% of VO2 max) on the cycle ergometer.  For exercise RER, minute 0 to 20  represents to the 
average RER of the given group after reaching 50% of VO2 max for submaximal exercise to the 
end of minute 20. A two-way ANOVA was used to compare the potentia for significant 
differences of RER between groups at each time point, RER of both groups at each time point, 
and RER within the group at each time point. There was no significant difference in exercise 
RER between High and Low group factor, or the group by time factor. Exercise RER for the 
Low Lactate Group was significantly higher from beginning of measurement at minute 0 to 5 







Figure 11. Lactate and Change of RER. RER was compared from resting to submaximal 
exercise  
* Significance P<0.05  
 
 
The change of RER from resting to submaximal exercise ΔRER of High (n=10) and 
Low(n=11) Lactate group was analyzed (Fig. 11). Pearson Product showed a correlation of 
R=0.6393, and r2=0.4088 (P=0.0466) in the High lactate Group. 
 





Figure 13. Absolute VO2 Max Comparison Between Groups (mean ± SEM) 
 
Lactate and VO2 Max 
 Absolute VO2 max of High (n=10) and Low (n=11) Lactate groups were determined 
using a Lode  Excalibur bike via indirect calorimetry (Fig. 12).  Pearson Product-Moment  
correlation coefficient was reported be to R=-0.3746 (Fig. 9) with both groups. No significance 
was found when a linear regression line was plotted. No significant difference was found in VO2 
max between groups using a unpaired two sample unpaired t-test (Fig. 13).  
 
 










VO2 max adjusted for FFM of High (n=10) and Low (n=11) Lactate groups of was 
plotted (Fig. 14). Pearson Product-Moment correlation coefficient was reported to be R=-0.7232, 
r2=0.523, linear regression line was plotted (p=0.0002) (Fig. 14). Low Lactate Group showed a 








Figure 16. Lactate and Deoxygenated Hemoglobin Rate 
 
 
Figure 17. Deoxygenated Hemoglobin Rate 
Comparison Between Groups (mean ± SEM) 
 
Lactate and Deoxygenated Hemoglobin Rate  
             Deoxygenated hemoglobin percent (deoxy Hb %) of High (n=10) and Low (n=11) 
Lactate group was analyzed using near infrared spectroscopy (NIRS) instrument (Fig. 16).  The 
coefficient of correlation for the Low Lactate Group was determined to be R=0.1366 with r2= 
0.0187, and the High Lactate Group reported R= 0.3064, with r2=0.0939. No significant 




Chapter V: Discussion 
 
  In our study, lactate was shown to have some association with REE in non-obese 
Caucasian females in the High Lactate Group. While not significant, subjects with high basal 
plasma lactate level showed a negative correlation with REE. This relationship became stronger 
when REE was adjusted FFM. Similarly, lactate and VO2 max adjusted for FFM was strongly 
associated. Subjects in the High Lactate Group displayed a positive relationship in ΔRER from 
resting to submaximal exercise. The inability for higher lactate individuals to match the same 
substrate as the lower lactate is an indicative of lower oxidative capacity.  
 There is no universally accepted value for basal lactate, but most literature reports levels 
as “normal” to be in the 0.5-1.0 mmol/L range. These individuals with "normal" lactate 
concentration present with the least morbidity for all diseases 9,11,80. People with obesity and/or 
Type 2 Diabetes display a wide range of basal lactate levels ranging from 4.0-10 mmol/L 11. 
While those diseases are multifactorial, we believe as one deviates further from the “normal” 
range for blood lactate, the lower daily REE would become, thus possibly contributing to obesity 
and/or Type 2 Diabetes. The first finding in the present study suggests overall there was no 
association with lactate and REE. When looking at the Low and High Lactate groups 
individually, the Low Lactate Group showed no correlation between lactate concentration and 
REE. The cut off for lactate concentration was a predetermined limitation to our design in the 
Low Lactate Group. It was unexpected that the lower spread was as narrow as 0.40 to 0.55 
mmol/L, along with a high variability of REE. As a result, the data range was too small to be 
included for an overall meaningful analysis. Conversely, the High Lactate Group had a wider 
lactate range from 0.85-1.80 mmol/L, which allowed for a correlation to be plotted. The High 





was plotted for the High lactate Group alone, no statistical significance was obtained 
(P=0.06015). In this context, it is important to note the characteristics of subjects were similar in 
terms BMI, physical activity level, along with no known cardiac or metabolic diseases. Despite 
the similarities, we were still able to see some association with lactate and REE.  
 In the obese, absolute REE is commonly reported to be higher than the leans 62. In our 
study, we were also interested to see if energy expenditure was different when REE is adjusted 
for FFM. Body composition was first analyzed between the two groups; no significance was 
found in either fat mass or fat free mass. We hypothesized the High Lactate Group would have a 
higher body fat percentage if there was going to be a difference in body composition. 
Interestingly, our study showed the Low Lactate Group had a significantly higher body fat 
percentage than the High Lactate Group (P=0.0442). Even though, we found significant 
difference in body fat percentage between groups, our subjects were non-obese and not different 
by a larger margin. We speculate that lifestyle factors such as diet and level of physical activity 
may have played a role in different body fat percentage between two groups. Upon analysis of 
REE adjusted for FFM, one outlier was detected, and no significant difference was found in 
adjusted REE between groups. When the correlation was plotted, adjusted REE for the High 
Lactate Group showed a negative correlation coefficient of R= - 0.6823 (Fig. 6) with statistical 
significance (r2=0.4656, P=0.0429). REE adjusted for FFM had a stronger association with 
lactate than comparing just REE alone.  
 While relationships were shown between blood lactate and REE within the High Lactate 
Group, it’s important to take note of the REE within the Low Lactate Group. Given the Low 
Lactate Group had a smaller range of lactate concentration; REE was highly variable (Fig. 4 and 




blood lactate may not be a good predictor of resting expenditure.  Within our results, High 
Lactate suggests that measurements of blood lactate could potentially used to predict lactate, 
while correlation of Low lactate groups is indicating that lactate is not associated with REE. 
Based on these data, it’s suggested that blood lactate measurement is less sensitive in predicting 
REE in the Low Lactate Group, and becomes more reliable as lactate increases, as shown in the 
High Lactate Group.  
 We believe that testing all 40 subjects would have help us draw a better conclusion 
between lactate and REE. Due to the time restraint and our limited budget, were unable to test all 
40 subjects. Instead, we thought selecting the higher and the lower lactate subjects would provide 
us with distinct difference in REE, but we know this is not the case within healthy non-obese 
subjects. In retrospect, we believe by including the middle 19 untested subjects for further testing 
would help us clarify if blood lactate could be a good overall predictor of REE. We 
acknowledged that excluding the Low Lactate Group in part of our analysis couldn’t fully justify 
the overall association of blood lactate and REE. However, the inverse relationship between 
blood lactate and REE within the High Lactate Group should also be acknowledged.  
 In previous studies, association was diminished when REE was adjusted to FFM. These 
studies implied energy expended adjusted to FFM was equally matched between both the leans 
and the obese. Even though our finding of REE adjusted for FFM is different in comparison, our 
result does not necessarily conflict with previous studies 81–83. One factor that may have been 
previously overlooked within those studies was not considering aerobic capacity when 
examining REE. Aerobic capacity is directly associated with cellular oxidative capacity, which 
may impact REE, as shown in the High Lactate Group. Thus, we also investigated aerobic 




adjusted to FFM was significantly higher in the Low Lactate Group (P=0.0001). In addition, 
lactate was shown to have an inverse relationship with aerobic capacity and adjusted REE (Fig. 6 
and 14). As plasma lactate level elevates, REE was lowered as a consequence of lower aerobic 
capacity. In support of our findings, Elbert et al. investigated energy expenditure and physical 
activity patterns between normal/overweight groups and different categories of obese groups, 
which was consistent with our data 84. In their experiment, adjusted activity thermogenesis and 
adjusted REE was observed to be significantly lowered as obesity progressed. Accordingly, we 
believe lactate levels are indication reflecting aerobic capacity, which possibility could, 
contributes to a lower rate of REE, at least in the High Lactate group.  
 Aerobic capacity is highly associated with all-cause mortality and morbidity 5,36, and it 
has been used as a one of the factors for explaining metabolic inflexibility. In determining 
aerobic capacity, VO2 peak was assessed in all of our participants. In our data, we found a 
negative correlation (R= -0.3746) between absolute VO2 peak and plasma lactate (Fig. 12). Our 
data therefore suggests that there was little to no relationship between the plasma lactate groups 
and absolute VO2 peak alone.  
Furthermore, we were also interested in examining aerobic capacity adjusted for FFM to 
analyze if aerobic capacity was equally matched per kilogram of lean mass. The adjusted VO2 
peak relationship with lactate became distinctively stronger (R= -0.7232, P=0.0002) compared to 
absolute VO2 peak alone. The Low Lactate Group showed a significantly higher VO2 adjusted to 
FFM (P<0.0001). Aerobic capacity has been shown to be a direct reflection of mitochondrial 
oxidative capacity and O2 delivery (capillary density) 43. The Low Lactate Group demonstrated a 





 In an attempt to further “unmask” potential relationships between plasma lactate 
concentrations and aerobic capacity; NIRS was used to study mitochondrial respiratory capacity 
between the lactate groups at the whole body level. Ryan et al. found measuring mitochondrial 
aerobic capacity with NIRS to be strongly correlated with measuring in situ for mitochondria 
respiration 85. In our experiment, NIRS showed no significant difference between High and Low 
Lactate groups. It is important to note that NIRS technology is highly variable with adipose 
tissue differences among subjects, which could explain absence of a significant difference 
between groups. The NIRS measurement was taken on participant’s vastus lateralis muscle of the 
left leg. Since females hold most of their adipose tissue in the lower body, it was challenging to 
get an accurate representation of deoxygenated hemoglobin, which was used to analyze the rate 
of oxygen utilization in determining mitochondria aerobic capacity. The fat distribution of the 
left leg of our participants ranged from 29.7-47.8%. Thus we detected a high variability between 
lactate concentrations and rate of oxygen kinetics (R=0.3064, Fig. 14). While NIRS measuring 
for mitochondrial aerobic capacity didn’t show a significant difference or a strong correlation as 
originally projected, the data is still agreeable with VO2 peak assessment when adjusted for 
FFM.  
 Our study showed relationship with increased lactate and reduced aerobic capacity. 
Plasma lactate level is a distinctive marker for aerobic capacity (Fig.14 and 15). The reflection of 
an inverse relationship between lactate and REE adjusted to FFM (Fig. 6) further suggest the 
non-obese with higher lactate may be experiencing energy alteration within the cell. Lactate 
detection might then potentially be served as a clinical biomarker in determining aerobic 
capacity and REE, as it may be a useful for disease prevention. This speculation requires further 




 Our data showed that plasma lactate reflects on aerobic capacity. We were also curious to 
determine potential relationships between lactate levels and the RER in the non-obese in 
determining their substrate utilization. High resting RER has been extensively studied in the 
obese Type 2 Diabetes individuals 19,45,46. RER reflects the carbohydrate and fat substrates 
utilized, and we were interested to see if plasma lactate concentration would be a factor to show 
distinct differences between the two groups. The resting RER was obtained when performing 
REE measurements. We hypothesized that the High Lactate Group would yield a higher resting 
RER concomitant with a higher plasma lactate production. We found no significant difference 
when resting RER was compared between two groups. However, a positive correlation 
(R=0.6295, r2=0.3963, P=0.05) was reported within the High Lactate Group (Fig. 8). The 
increased lactate concentration corresponded to the increase resting RER, which suggests 
individuals with high lactate levels were utilizing more glucose at rest.  Furthermore, resting 
RER was analyzed during 5-minute time points within the 20-minute measurement between 
High Lactate and Low Lactate Groups (Fig. 9). No statistical difference in resting RER was 
found between groups within each time points, or at each time point within each group. Although 
there was no significance, the High Lactate Group elicited a higher average resting RER than 
Low Lactate Group throughout the 20-minute measurement. This was still important to take 
notice of when accounting for the similar characteristics of our subjects. A possible explanation 
may be that the High Lactate Group has a lower composition of type I oxidative muscle fibers. 
Type I muscle fibers have higher mitochondrial and capillary density 86, which could reduce the 
production of lactate. Our results disprove our hypothesis, as RER did not show a distinct 




postulate that High Lactate Group may have not yet completely reached the characteristics of 
obesity or Type 2 Diabetes.  
  Submaximal exercise RER was also measured for 20 minutes with the introduction of 
low intensity exercise (Fig. 10). The workload was set as close to 50% of subject’s VO2 peak 
(ranged 50-60% of subjects’ VO2 peak) on the cycle ergometer. The acclimation took 2-3 
minutes before the 20-minute measurement. We were interested in the response of substrates 
switching during the protocol. No significant difference was found between groups throughout 
the 20 minutes. The exercise RER for both groups increased simultaneously when exercise was 
induced. However, RER response in the Low Lactate Group increased significantly from the 
start at minute 0 to minute 5, minute 0 to 10, minute 0 to 15, and minute 0 to 20 (Fig. 9). No 
significant difference was found in the High Lactate Group throughout the time of exercise. The 
Low Lactate Group was able to noticeably switch to more carbohydrate utilization from the start 
of the exercise and sustain their exercise RER throughout the rest of exercise. The High Lactate 
Group also shifted to more carbohydrate substrate, but showed no significant difference over any 
given time point during the exercise. Higher exercise RER was more prominent in High Lactate 
Group, and it was consistent from the start of the measurement to the end. It was not until the 
20th minute that exercises RER for the High Lactate Group dropped closer to the Low Lactate 
Group. Given sufficient time, we observed that the High Lactate Group could adapt to more fat 
substrate utilization similar level to the Low Lactate Group between minute 15 and 20.  
The inability for the High Lactate Group to match a lower RER in the beginning of 
exercise could be indicative of metabolic inflexibility. Accordingly, lactate and ΔRER was 
shown to be positively correlated with statistical significance (R=0.6393, P<0.05). This 




by the low intensity. However, longer measurements of exercise RER data would be needed to 
determine if the High Lactate Group was experiencing an adaptation in substrate shifting. To 
expand, the term metabolic inflexibility has been coined by Kelly and colleagues referring that 
the ability for substrate transition of carbohydrate when fat is limited 15,76,42. While the 
mechanisms for metabolic inflexibility is presently open to debate, it is commonly observed in 
people who are obese, have Type 2 Diabetes, and/or are sedentary 18,19,45. While our exercise 
RER data showed no significant difference between groups (Fig. 10), higher lactate might 
potentially be an indicative factor limiting the ability to adapt to substrate utilization.  
 The trend of higher RER in the High Lactate Group was consistent at both resting or 
during exercise (Fig. 8,9,10, and 11). We believe that this was one of the outcomes subsequent 
from elevated lactate that is independent from body composition within the non-obese. 
Previously in a study by Goodpastor et al., it was reported that a higher body fat percentage is 
associated with a higher RER 87. The study showed that free fatty acid oxidation is related to a 
subject’s body fat proportion during moderate exercise. In our results, body fat percentage was 
found to be significantly higher in the Low Lactate Group. This observation leads to the 
suspicion that a higher fat oxidation may be more related to a higher amount of body fat, instead 
of a higher aerobic capacity. While this conjecture is sensible, it’s important to note that the 
comparison made in the previous study was comparing leans to obese individuals across a large 
range of BMIs, opposed to our matched model examining individuals with resting lactate levels 
that represent the lowest and highest lactate. Additionally, the exercise intensities studied in the 
past were higher compared to the present study. Therefore, the past literature examining fat 
oxidation relative to body fat may be misrepresenting the present findings due to different 




suggest that body fat is not proportional to fatty acid oxidation 88. The intensity of the exercise 
(45% VO2 max), and their subject’s characteristics (non-obese) were more appropriately 
matched to our model. The Low Lactate Group showed a lower exercise RER response at each 
time point, perhaps due to a higher aerobic capacity, which is independent from higher body fat 
percentage.  
Summary 
 Increasing lactate above the normal range demonstrated some association with decreasing 
REE in the High Lactate Group (r2=0.3712, P=0.0615). The inverse relationship became stronger 
when REE was adjusted to subject’s body weight (r2=0.4656, P=0.0429). However, resting and 
exercise RER were not different between groups over exercise time. While not significant, it is 
important to mention lactate and resting RER are positively associated within the High Lactate 
Group (r2=0.3963, P=0.0511). Additionally, ΔRER from resting to submaximal exercise was 
strongly associated (r2=0.4088, P=0.0466). No statistical significance was noted in the absolute 
VO2 peak when compared to High and Low Lactate groups. Surprisingly, aerobic capacity 
adjusted to FFM was significant higher in Low Lactate Group (P<0.0001). Lactate and adjusted 
VO2 peak showed to have a strong association (r2=0.5230, P=0.0002). 
Conclusion 
 It was unclear if people developed traits of obesity and Type 2 Diabetes before or after 
they’ve developed the disease. Decreasing energy expenditure was one of the traits that we 
thought was prominent in the obese and people who have Type 2 Diabetes. We believed that 
REE would be distinguish between individuals with low versus high plasma lactate and that 
stronger difference would become evident as resting lactate increases. Our experimental findings 




mmol/L), which was displayed in our High Lactate Group. This implies that the early signs of 
elevated lactate may be an indication of energy alteration within the body as a whole. 
Concurrently, resting RER also increased with lactate. In the resting state, subjects with a higher 
lactate level utilized more carbohydrates than fat. Lactate and the adaptability of substrate 
utilization (ΔRER) shared a positive relationship. The inability for higher lactate individuals to 
match the same substrate utilized as the lower lactate may be indicative of a lesser mitochondrial 
and capillary density. Not only lactate and aerobic capacity were inversely associated, VO2 peak 
adjusted to FFM was significantly higher in the Low Lactate Group. It is important to note that 
we didn’t control for physical activity level as a limitation of our study. The participants were all 
non-regular exercisers, but their physical activity level may vary from person to person, which is 
something to consider when looking at the results of our study.  Overall, measurement of blood 
lactate concentrations may be a reflection of aerobic capacity, and substrate utilization during 
resting and exercise. Thus, further studies are needed with larger subject recruitment to 
determine the potential clinical adoption of lactate levels as a biomarker for the predisposal 
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